Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL1289960

NCC(=O)NCC(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.35

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 1/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
POLB P06746 3/20 0.34
LMNA P02545 2/20 0.34
LOXL2 Q9Y4K0 1/20 0.34
KDM4E B2RXH2 4/20 0.33
ALDH1A1 P00352 3/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
MEN1 O00255 1/20 0.32
HPGD P15428 1/20 0.32
KMT2A Q03164 1/20 0.32
GAA P10253 1/20 0.31
CACNA1H O95180 1/20 0.31
AOC3 Q16853 1/20 0.31
GLRA1 P23415 1/20 0.31
SLC6A9 P48067 1/20 0.31
OR51E2 Q9H255 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL981619 0.91 LMNA (0.38) SMN1; SMN2POLBLMNALOXL2KDM4E
Bromide SCHEMBL29450513 0.89 LMNA (0.37) SMN1; SMN2POLBLMNALOXL2KDM4E
Hydrochloric Acid SCHEMBL1289973 0.89 LMNA (0.37) SMN1; SMN2POLBLMNALOXL2KDM4E
Sulfuric Acid SCHEMBL1289861 0.83 CA1 (0.36) SMN1; SMN2POLBLMNALOXL2KDM4E
Trifluoroacetic Acid SCHEMBL13519111 0.79 MCL1 (0.38) MMP2SMN1; SMN2POLBALDH1A1MEN1
Trifluoroacetic Acid SCHEMBL28343191 0.78 ALDH1A1 (0.39) MMP2SMN1; SMN2POLBLMNAKDM4E
Trifluoroacetic Acid SCHEMBL11288932 0.76 ITGB1 (0.38) MMP2LMNAKDM4EALDH1A1CACNA1H
Trifluoroacetic Acid SCHEMBL11688514 0.76 CA2 (0.40) MMP2KDM4EMEN1KMT2AGLRA1
Trifluoroacetic Acid SCHEMBL17727570 0.75 KDM1A (0.33) MMP2
Trifluoroacetic Acid SCHEMBL7711992 0.75 NPC1 (0.33) MMP2SMN1; SMN2POLBLMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3150575-B1 METHOD FOR PREPARING 2-AMINO-N-(2,2,2-TRIFLUOROETHYL) ACETAMIDE DU PONT (US) 2023-08-09 EP disclosed
US-11613516-B2 Method for preparing 2-amino-n-(2,2,2-trifluoroethyl) acetamide E. I. DU PONT DE NEMOURS AND COMPANY (US) 2023-03-28 US disclosed
US-10745344-B2 Method for preparing 2-amino-N-(2,2,2-trifluoroethyl) acetamide E. I. DU PONT DE NEMOURS AND COMPANY (US) 2020-08-18 US disclosed
US-20190144374-A1 METHOD FOR PREPARING 2-AMINO-N-(2,2,2-TRIFLUOROETHYL) ACETAMIDE CORTEVA AGRISCIENCE LLC 2019-05-16 US disclosed
US-20190144373-A1 METHOD FOR PREPARING 2-AMINO-N-(2,2,2-TRIFLUOROETHYL) ACETAMIDE CORTEVA AGRISCIENCE LLC 2019-05-16 US disclosed
US-10202332-B2 Method for preparing 2-amino-N-(2,2,2-trifluoroethyl) acetamide E. I. DU PONT DE NEMOURS AND COMPANY (US) 2019-02-12 US disclosed
EP-3150575-A1 METHOD FOR PREPARING 2-AMINO-N-(2,2,2-TRIFLUOROETHYL) ACETAMIDE E. I. du Pont de Nemours and Company (US) 2017-04-05 EP disclosed
EP-2621894-B1 METHOD FOR PREPARING 2-AMINO-N-(2,2,2-TRIFLUOROETHYL) ACETAMIDE DU PONT (US) 2016-11-16 EP disclosed
CN-103124721-B Method for preparing 2-amino-n-(2,2,2-trifluoroethyl) acetamide DU PONT 2015-06-03 CN disclosed
US-20130267729-A1 METHOD FOR PREPARING 2-AMINO-N-(2,2,2-TRIFLUOROETHYL) ACETAMIDE E.I. DU PONT DE NEMOURS AND COMPANY (US) 2013-10-10 US disclosed
EP-2621894-A1 METHOD FOR PREPARING 2-AMINO-N-(2,2,2-TRIFLUOROETHYL) ACETAMIDE E.I. Du Pont De Nemours And Company (US) 2013-08-07 EP disclosed
CN-103124721-A Method for preparing 2-amino-n-(2,2,2-trifluoroethyl) acetamide DU PONT 2013-05-29 CN disclosed
US-8383659-B2 Isoxazoline derivatives as pesticides NOVARTIS AG (CH) 2013-02-26 US disclosed
WO-2012047543-A1 METHOD FOR PREPARING 2-AMINO-N-(2,2,2-TRIFLUOROETHYL) ACETAMIDE E.I. DU PONT DE NEMOURS AND COMPANY (US) 2012-04-12 WO disclosed
US-20110245239-A1 ORGANIC COMPOUNDS ELANCO TIERGESUNDHEIT AG (CH) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10202332-B2 Method for preparing 2-amino-N-(2,2,2-trifluoroethyl) acetamide NAAA, SAT1, NAA15 MMP2 3483/4885SMN1; SMN2 433/4885POLB 2887/4885
US-11613516-B2 Method for preparing 2-amino-n-(2,2,2-trifluoroethyl) acetamide NAAA, SAT1, NAA15 MMP2 3483/4885SMN1; SMN2 433/4885POLB 2887/4885
US-10745344-B2 Method for preparing 2-amino-N-(2,2,2-trifluoroethyl) acetamide NAAA, SAT1, NAA15 MMP2 3483/4885SMN1; SMN2 433/4885POLB 2887/4885
US-20110245239-A1 ORGANIC COMPOUNDS ACHE, VDAC1, VDAC2 MMP2 867/4885SMN1; SMN2 648/4885POLB 2491/4885
US-20190144374-A1 METHOD FOR PREPARING 2-AMINO-N-(2,2,2-TRIFLUOROETHYL) ACETAMIDE NAAA, SAT1, NAA15 MMP2 3483/4885SMN1; SMN2 433/4885POLB 2887/4885
US-20190144373-A1 METHOD FOR PREPARING 2-AMINO-N-(2,2,2-TRIFLUOROETHYL) ACETAMIDE NAAA, SAT1, NAA15 MMP2 3483/4885SMN1; SMN2 433/4885POLB 2887/4885
US-20130267729-A1 METHOD FOR PREPARING 2-AMINO-N-(2,2,2-TRIFLUOROETHYL) ACETAMIDE NAAA, SAT1, NAA15 MMP2 3483/4885SMN1; SMN2 433/4885POLB 2887/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.